Fusco, C <br/><br/>
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis.  [electronic resource] 

 -  Neurology  Dec 2001 
 - 1976-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.57.11.1976  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alleles<br/>Female<br/>Glatiramer Acetate<br/>HLA-DR Antigens--genetics<br/>HLA-DRB1 Chains<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--adverse effects<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--diagnosis<br/>Neurologic Examination--drug effects<br/>Patient Selection<br/>Peptides--adverse effects<br/>Prognosis